Solstice Corp. – Trademark Portfolio
Entity Type: 03
Solstice Corp. holds 4 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 4 Nice Classification classes. Currently, 1 trademark is registered and 3 are pending. Notable registered marks include XACT. The owner is based in Portland, ME.
P.O. Box 1177
Portland, ME 04104
Showing of trademarks Trademarks
Trademark Classifications
Solstice Corp.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Solstice Corp. have?
Solstice Corp. has 4 U.S. trademarks filed with the USPTO. Of these, 1 registered, 3 pending.
What trademark classes does Solstice Corp. file in?
Solstice Corp. files trademarks across 4 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 9 (Computers & Electronics), Class 3 (Cosmetics & Cleaning), Class 5 (Pharmaceuticals). Class 35 covers advertising; business management; business administration; office functions.
What are Solstice Corp.'s most well-known trademarks?
Solstice Corp.'s registered trademark portfolio includes well-known marks such as XACT. These are among 1 currently registered trademark in the portfolio.
What is Solstice Corp.'s trademark registration success rate?
Solstice Corp. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 3 applications are pending review.